# Integrated Treatment for Cocaine and Mood Disorders - 1

> **NCT00227812** · PHASE2 · COMPLETED · sponsor: **National Institute on Drug Abuse (NIDA)** · enrollment: 140 (—)

## Conditions studied

- Cocaine Dependence
- Depressive Disorder, Major

## Interventions

- **DRUG:** Bupropion

## Key facts

- **NCT ID:** NCT00227812
- **Lead sponsor:** National Institute on Drug Abuse (NIDA)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-04
- **Primary completion:** 2005-12
- **Final completion:** 2005-12
- **Target enrollment:** 140 (—)
- **Last updated:** 2017-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00227812

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00227812, "Integrated Treatment for Cocaine and Mood Disorders - 1". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT00227812. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*